Skip to main content

Study on Adsorption and Sustained Release of Eucommia ulmoides Oliv. Leaf Extracts on Activated Carbon

Buy Article:

$68.00 + tax (Refund Policy)

Background: Due to its excellent adsorption capability, activated carbon(AC) has also been employed as a drug carrier. However, applications of the AC carrier in traditional Chinese medicine (TCM) have been rare. We selected the Eucommia ulmoides leaf extract as the drug of choice and AC as its carrier, to investigate the adsorption and sustained release behavior of the Eucommia ulmoides leaf extract on the AC.

Methods: AC was employed in this study as the sustained release carrier and its capability for adsorption and sustained release of Eucommia ulmoides leaf extracts was systematically investigated. Acid or alkali modified AC was assessed for its ability to absorb and sustain release of Eucommia ulmoides leaf extracts according to a variety of adsorption/release rate and composition.

Results: Results demonstrated that the adsorption rate for the differently modified AC reached above 80 %, whereas the adsorption of Eucommia ulmoides leaf extracts on the AC was selective. The composition of the sustained release liquid, which was treated by the acid modified AC, was almost similar to the original extract. The acid modified AC was therefore taken as an optimal carrier that can be used for Eucommia ulmoides leaf extracts sustained release.

Conclusion: The synchronous release and absorption of different ingredients in the active ingredient release process ensures the global and cooperative effect with sustained and less toxic advantages. The ideal synchronous release is that the absorbed component proportion is consistent with its release. The acid modified AC was therefore taken as the optimal carrier that can be used for Eucommia ulmoides leaf extracts sustained release.

Keywords: Carbon; Eucommia ulmoides Oliv. leaf; adsorption; cytotoxicity; polylactic acid; release

Document Type: Research Article

Publication date: 01 February 2018

More about this publication?
  • The aim of Current Drug Delivery is to publish peer-reviewed articles, short communications, short and in-depth reviews in the rapidly developing field of drug delivery. Modern drug research aims to build in delivery properties of a drug at the design phase, however in many cases this ideal cannot be met and the development of delivery systems becomes as important as the development as the drugs themselves.

    The journal aims to cover the latest outstanding developments in drug and vaccine delivery employing physical, physico-chemical and chemical methods. The drugs include a wide range of bioactive compounds from simple pharmaceuticals to peptides, proteins, nucleotides, nucleosides and sugars. The journal will also report progress in the fields of transport routes and mechanisms including efflux proteins and multi-drug resistance.

    The journal is essential for all pharmaceutical scientists involved in drug design, development and delivery.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content